25 May 2013
Keywords: qlt, phototherapeutics, appointment, lawrence, mandt, been, appointed
Article | 16 September 1999
At QLT PhotoTherapeutics, Lawrence Mandt has been appointed vicepresident of regulatory affairs. Mr Mandt joins from Novartis' CIBA Vision.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.